Bessemer Group Inc. Sells 5,112 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Bessemer Group Inc. lowered its position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 64.7% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,786 shares of the company's stock after selling 5,112 shares during the quarter. Bessemer Group Inc.'s holdings in HCA Healthcare were worth $962,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Brighton Jones LLC bought a new stake in shares of HCA Healthcare in the 4th quarter worth approximately $1,021,000. Oppenheimer Asset Management Inc. increased its holdings in shares of HCA Healthcare by 3.1% during the fourth quarter. Oppenheimer Asset Management Inc. now owns 4,209 shares of the company's stock valued at $1,263,000 after acquiring an additional 125 shares in the last quarter. SVB Wealth LLC bought a new position in HCA Healthcare in the 4th quarter worth about $1,003,000. Fisher Asset Management LLC raised its holdings in HCA Healthcare by 37.8% in the fourth quarter. Fisher Asset Management LLC now owns 872 shares of the company's stock worth $262,000 after buying an additional 239 shares during the last quarter. Finally, US Bancorp DE grew its holdings in shares of HCA Healthcare by 5.6% during the fourth quarter. US Bancorp DE now owns 18,214 shares of the company's stock valued at $5,467,000 after buying an additional 965 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several equities analysts recently issued reports on the company. Barclays set a $416.00 price objective on HCA Healthcare and gave the company an "overweight" rating in a research report on Monday, June 2nd. Baird R W downgraded HCA Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Royal Bank Of Canada reaffirmed an "outperform" rating and set a $404.00 price target (up previously from $376.00) on shares of HCA Healthcare in a report on Monday, June 23rd. Stephens upgraded shares of HCA Healthcare to a "strong-buy" rating in a research report on Monday, June 2nd. Finally, Wells Fargo & Company upgraded shares of HCA Healthcare from an "underweight" rating to an "equal weight" rating and boosted their target price for the company from $320.00 to $385.00 in a research note on Thursday, May 29th. Eight research analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, HCA Healthcare has an average rating of "Moderate Buy" and a consensus price target of $395.71.

HCA Healthcare Stock Performance

NYSE HCA traded down $7.86 on Wednesday, reaching $381.67. 209,113 shares of the stock were exchanged, compared to its average volume of 1,457,660. The company's 50-day simple moving average is $369.16 and its two-hundred day simple moving average is $337.94. The company has a current ratio of 1.19, a quick ratio of 1.06 and a debt-to-equity ratio of 69.07. The firm has a market capitalization of $91.82 billion, a PE ratio of 16.98, a PEG ratio of 1.32 and a beta of 1.47. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $5.75 by $0.70. HCA Healthcare had a return on equity of 1,063.91% and a net margin of 8.07%. The business had revenue of $18.32 billion during the quarter, compared to analyst estimates of $18.26 billion. During the same quarter in the prior year, the business posted $5.36 EPS. HCA Healthcare's revenue for the quarter was up 5.7% compared to the same quarter last year. Analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, June 30th. Investors of record on Monday, June 16th were paid a dividend of $0.72 per share. The ex-dividend date of this dividend was Monday, June 16th. This represents a $2.88 annualized dividend and a yield of 0.75%. HCA Healthcare's payout ratio is 12.81%.

Insider Activity

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of HCA Healthcare stock in a transaction that occurred on Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total value of $5,797,585.36. Following the sale, the chief operating officer owned 12,646 shares of the company's stock, valued at $4,670,420.72. The trade was a 55.38% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Company insiders own 1.30% of the company's stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.